POULTRY’S PERCH
The research performed by the FDA lacks the scrutiny necessary to justify its rushed judgment concerning the use of Roxarsone in poultry feed diets.
Although the benefits realized from the use of arsenicals are numerous, the Food and Drug Administration apparently requested the drug’s manufacturer, Alpharma, a subsidiary of Pfizer, to withdraw it from the market after completing a study that assessed arsenic levels in birds fed Roxarsone. While research is the mainstay of the poultry industry’s efficacy, the research performed by the FDA lacks the scrutiny necessary to justify FDA's rushed judgment concerning the use of Roxarsone in poultry feed diets.
Read more